FIELD: medicine.
SUBSTANCE: claimed invention relates to medicine, in particular to device for transdermal bisoprolol introduction, which includes base and layer of sensitive to pressure adhesive, which contains bisoprolol, which is layered on one base surface, where maximal value of bisoprolol release in time period immediately from application on skin within 24 hours constitutes 30 mcg/cm2/hour or less; and where velocity of bisoprolol release 24 hours after application on skin constitutes 10 mcg/cm2/hour or less.
EFFECT: device for transdermal introduction reduces skin irritation, especially in case of layering, and can constantly introduce into living organism therapeutically or preventively efficient amount of bioprolol.
5 cl, 3 tbl, 3 dwg, 3 ex
Title | Year | Author | Number |
---|---|---|---|
TRANSDERMAL GRANISETRON | 2004 |
|
RU2355387C2 |
METHOD AND TRANSDERMAL THERAPEUTIC SYSTEM FOR EXERTING SEDATIVE INFLUENCE UPON PATIENT | 1992 |
|
RU2098083C1 |
TRANSDERMAL THERAPEUTIC SYSTEM CONTAINING AZENAPINE AND POLYSILOXANE OR POLYISOBUTYLENE | 2017 |
|
RU2764443C2 |
TRANSDERMAL PLASTER | 2006 |
|
RU2420269C2 |
INTENSIFIER OF PERCUTANEOUS SUCTION AND TRANSDERMAL MEDICATION WITH ITS APPLICATION | 2009 |
|
RU2504363C2 |
TRANSDERMAL DONEPEZIL DELIVERY SYSTEM | 2017 |
|
RU2779471C2 |
TRANSDERMAL SYSTEM FOR VARENICLINE | 2006 |
|
RU2388461C2 |
TRANSDERMAL DEVICE, INCLUDING POROUS MICROPARTICLES | 2013 |
|
RU2627869C2 |
ADHESIVE PHARMACEUTICAL BISOPROPOL-CONTAINING COMPOSITION | 2006 |
|
RU2396951C2 |
TAPE-APPLIED PHENTHANYL-CONTAINING PREPARATION FOR PERCUTANEOUS USAGE | 1997 |
|
RU2194496C2 |
Authors
Dates
2012-01-27—Published
2008-03-06—Filed